FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,156,000 | +994.8% | 296,139 | +394.1% | 0.05% | +1125.0% |
| Q4 2020 | $1,019,000 | +25.0% | 59,929 | -65.4% | 0.00% | +33.3% |
| Q3 2020 | $815,000 | -38.3% | 173,336 | -19.9% | 0.00% | -57.1% |
| Q2 2020 | $1,320,000 | +149.1% | 216,444 | -7.2% | 0.01% | +133.3% |
| Q1 2020 | $530,000 | -78.9% | 233,343 | -57.4% | 0.00% | -62.5% |
| Q4 2019 | $2,513,000 | -51.5% | 547,586 | -59.0% | 0.01% | -57.9% |
| Q3 2019 | $5,180,000 | -26.0% | 1,336,847 | +15.2% | 0.02% | -24.0% |
| Q2 2019 | $6,997,000 | -11.9% | 1,160,411 | +95.9% | 0.02% | -16.7% |
| Q1 2019 | $7,938,000 | +65.0% | 592,394 | +14.5% | 0.03% | +42.9% |
| Q4 2018 | $4,810,000 | +4710.0% | 517,241 | +8110.2% | 0.02% | – |
| Q2 2018 | $100,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |